EVE Stock Overview
Engages in the retail and distribution of health and wellness products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
EVE Health Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.001 |
| 52 Week High | AU$0.001 |
| 52 Week Low | AU$0.001 |
| Beta | 0.94 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 33 Year Change | -75.00% |
| 5 Year Change | -80.00% |
| Change since IPO | -96.67% |
Recent News & Updates
Shareholder Returns
| EVE | AU Food | AU Market | |
|---|---|---|---|
| 7D | 0% | -0.1% | 1.5% |
| 1Y | 0% | 11.2% | 17.2% |
Return vs Industry: EVE underperformed the Australian Food industry which returned 11.2% over the past year.
Return vs Market: EVE underperformed the Australian Market which returned 17.2% over the past year.
Price Volatility
| EVE volatility | |
|---|---|
| EVE Average Weekly Movement | n/a |
| Food Industry Average Movement | 7.2% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 17.3% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: EVE's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: Insufficient data to determine EVE's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | Bill Fry | www.evehealthgroup.com.au |
EVE Health Group Limited, together with its subsidiaries, engages in the retail and distribution of health and wellness products. The company offers organic raw honey and raw honey probiotic concentrates; and contract manufacturing services. It also sells its products through online store.
EVE Health Group Limited Fundamentals Summary
| EVE fundamental statistics | |
|---|---|
| Market cap | AU$5.27m |
| Earnings (TTM) | -AU$1.55m |
| Revenue (TTM) | AU$2.13m |
2.5x
P/S Ratio-3.4x
P/E RatioIs EVE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EVE income statement (TTM) | |
|---|---|
| Revenue | AU$2.13m |
| Cost of Revenue | AU$1.26m |
| Gross Profit | AU$876.96k |
| Other Expenses | AU$2.43m |
| Earnings | -AU$1.55m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00029 |
| Gross Margin | 41.10% |
| Net Profit Margin | -72.58% |
| Debt/Equity Ratio | 6.1% |
How did EVE perform over the long term?
See historical performance and comparison